CAS NO: | 537034-15-4 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | NKL 22 (compound 4b) is a potent and selective inhibitor ofhistone deacetylases (HDAC), with anIC50of 199 and 69 nM forHDAC1andHDAC3, respectively. NKL 22 exhibits selectivity over HDAC2/4/5/7/8 (IC50≥1.59 μM). NKL 22 ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice[1][2][3]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
分子量 | 325.40 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C19H23N3O2 | ||||||||||||||||
CAS 号 | 537034-15-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(307.31 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |